Providence Medical Center, in collaboration with the Mayo Clinic, is now
part of a nationwide study, looking at the utilization of convalescence
plasma as a therapy for COVID-19.
Sabato Sisillo, MD, Providence Chief Medical Officer, who is a Pulmonologist
and Critical Care Specialist, along with Samir Desai, MD, Infectious Disease Specialist,
are the Principal investigators for the Medical Center. They will be collaborating
with Mayo Clinic to identify and enroll possible patients into this study.
According to these physicians, a Providence patient this week will begin
to receive convalescence plasma.
“We look forward to participating in this study as we all work towards
aggressive steps in the fight against COVID-19 in our local community,”
said Dr. Sisillo.
According to the Mayo Clinic, the treatment is based on the function of
antibodies, proteins created by the immune system that combat invaders
to the body in a variety of ways. Some are capable of neutralizing a virus,
while others work by mobilizing a range of other immune cells that fight
off disease. It's not yet known by which mechanism COVID-19 antibodies
might work, but the thinking is that an infusion of convalescent plasma
may boost a generalized response, known as passive immunity, until a patient
develops a strong, targeted ability to fight the virus.